Target intelligence / Profile preview

Ribonucleotide Reductase Regulatory Subunit M1 (None)

Target
None
Molecular classification
Enzyme
01

Overview

Ribonucleotide reductase regulatory subunit M1 (RRM1) is the large, catalytic subunit of ribonucleotide reductase (RNR), an essential enzyme for DNA synthesis and repair. RNR catalyzes the conversion of ribonucleotides to deoxyribonucleotides, providing the building blocks required for DNA replication and repair in all dividing cells. It forms a hetero-oligomeric complex with smaller regulatory subunits—M2 or p53R2—to constitute active human ribonucleotide reductase. The M1/RRM1 subunit contains the catalytic site responsible for substrate reduction and two distinct allosteric sites that regulate both overall activity and substrate specificity through effector binding. Its expression and role in DNA synthesis make it a target in cancer therapy.

Other names
RRM1RR1Ribonucleoside-diphosphate reductase large subunitRibonucleotide reductase M1
02

Mechanism of action

Inhibition of ribonucleotide reductase, leading to decreased dNTP production and impaired DNA synthesis

03

Biological functions

CatalysisAllosteric regulation of dNTP synthesisDNA synthesisDNA repairRegulation of nucleotide pools
04

Disease associations

CancerBeckwith-Wiedemann syndromeWilms tumorRhabdomyosarcomaAdrenocortical carcinomaLung cancerOvarian cancerBreast cancer
05

Biomarkers

RRM1 mRNA expression levels (prognostic in CLL)

Beyond the preview

Go deeper on Ribonucleotide Reductase Regulatory Subunit M1 (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribonucleotide Reductase Regulatory Subunit M1 (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call